Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers

doi:10.4251/wjgo.v14.i10.1892

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 10

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4323)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

167

WORD

HTML

1934

Figures (1-3)

274

Tables (1-2)

260

Sum=2674

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

190

Download

497

Sum=687

Publishing Process of This Article

Item

Count

Browse

288

Download

674

Sum=962

Oct 15, 2022 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastrointest Oncol. Oct 15, 2022; 14(10): 1892-1902
Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.1892

Full Size Figure Download Figure

Figure 3 The participating pathways of Go-Ichi-Ni-San 2. GINS2: Go-Ichi-Ni-San 2; MAPK: Mitogen-activated protein kinase; ERK: Extracellular signal-regulated kinase; STAT: Signal transducers and activator; EMT: Epithelial-mesenchymal transition; MAPKKK: MAP kinase kinase kinase; MMPs: Matrix metalloproteinases; MEK: Mitogen-activated protein kinase; MKK3/6: MAP kinase kinase 3/6; MCM2: Minichromosome maintenance complex component 2; CHEK2: Checkpoint kinase 2; ATM: Ataxia telangiectasia mutated; CHK2: Cell kinase cyclecheckpoint2; PTP4A1: Protein tyrosine phosphatase 4A1; CITED2: Cbp/P300-interacting transcription factor 2; LOXL2: Lysyl oxidase like 2; GADD45A: Growth arrest and DNA damage inducible alpha; JAK: Janus kinase; mTOR: Mammalian target of rapamycin.

Citation: Shan DD, Zheng QX, Chen Z. Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers. World J Gastrointest Oncol 2022; 14(10): 1892-1902
URL: https://www.wjgnet.com/1948-5204/full/v14/i10/1892.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.1892